Global AI Pathology Analysis System Supply, Demand and Key Producers, 2026-2032
Description
The global AI Pathology Analysis System market size is expected to reach $ 336 million by 2032, rising at a market growth of 15.8% CAGR during the forecast period (2026-2032).
The AI pathology analysis system is a medical diagnostic tool based on artificial intelligence technology. It automatically analyzes and identifies pathology slice images through deep learning algorithms, assisting pathologists in quickly and accurately detecting diseases such as cancer and inflammation. The system can extract features from massive pathology data, identify subtle lesions, and provide diagnostic suggestions, significantly improving diagnostic efficiency and accuracy while reducing human errors, providing strong support for precision medicine and personalized treatment.
AI-powered pathology analysis systems are entering a golden window of opportunity driven by policy, technology, and capital. Many national health insurance agencies have already included AI-assisted diagnosis in their billing schemes. Technologically, the system is moving from "single-model disease-specific" to a "one-model-multiple-disease" era of large-scale pathology models, with single-slice AI analysis time reduced to the second level, and diagnostic sensitivity significantly improved, particularly in the identification of small metastases. As open-source models reduce the cost of private deployment, penetration rates in primary hospitals are expected to rise rapidly. Future competition will focus on data coverage, generalization capabilities, and the construction of a closed-loop clinical payment system.
This report studies the global AI Pathology Analysis System demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Pathology Analysis System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Pathology Analysis System that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Pathology Analysis System total market, 2021-2032, (USD Million)
Global AI Pathology Analysis System total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI Pathology Analysis System total market, key domestic companies, and share, (USD Million)
Global AI Pathology Analysis System revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI Pathology Analysis System total market by Type, CAGR, 2021-2032, (USD Million)
Global AI Pathology Analysis System total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI Pathology Analysis System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Visiopharm, PathAI, Aiforia, Indica Labs, aetherAI, Proscia, Mindpeak, Techcyte, Qritive, Deepathology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI Pathology Analysis System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI Pathology Analysis System Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global AI Pathology Analysis System Market, Segmentation by Type:
On-premises
Cloud-based
Global AI Pathology Analysis System Market, Segmentation by Technical Architecture:
Single-Task Dedicated Model
Multi-Task General Model
Multimodal Fusion Model
Global AI Pathology Analysis System Market, Segmentation by Clinical Application Functions:
Assisted Screening System
Quantitative Analysis System
Staging and Grading System
Prognostic Prediction System
Companion Diagnostic System
Global AI Pathology Analysis System Market, Segmentation by Application:
Hospital
Clinic
Others
Companies Profiled:
Visiopharm
PathAI
Aiforia
Indica Labs
aetherAI
Proscia
Mindpeak
Techcyte
Qritive
Deepathology
Franklin.ai
Roche Diagnostics
Flagship
Dedalus Group
Ibex Medical Analytics
Key Questions Answered
1. How big is the global AI Pathology Analysis System market?
2. What is the demand of the global AI Pathology Analysis System market?
3. What is the year over year growth of the global AI Pathology Analysis System market?
4. What is the total value of the global AI Pathology Analysis System market?
5. Who are the Major Players in the global AI Pathology Analysis System market?
6. What are the growth factors driving the market demand?
The AI pathology analysis system is a medical diagnostic tool based on artificial intelligence technology. It automatically analyzes and identifies pathology slice images through deep learning algorithms, assisting pathologists in quickly and accurately detecting diseases such as cancer and inflammation. The system can extract features from massive pathology data, identify subtle lesions, and provide diagnostic suggestions, significantly improving diagnostic efficiency and accuracy while reducing human errors, providing strong support for precision medicine and personalized treatment.
AI-powered pathology analysis systems are entering a golden window of opportunity driven by policy, technology, and capital. Many national health insurance agencies have already included AI-assisted diagnosis in their billing schemes. Technologically, the system is moving from "single-model disease-specific" to a "one-model-multiple-disease" era of large-scale pathology models, with single-slice AI analysis time reduced to the second level, and diagnostic sensitivity significantly improved, particularly in the identification of small metastases. As open-source models reduce the cost of private deployment, penetration rates in primary hospitals are expected to rise rapidly. Future competition will focus on data coverage, generalization capabilities, and the construction of a closed-loop clinical payment system.
This report studies the global AI Pathology Analysis System demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Pathology Analysis System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Pathology Analysis System that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Pathology Analysis System total market, 2021-2032, (USD Million)
Global AI Pathology Analysis System total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI Pathology Analysis System total market, key domestic companies, and share, (USD Million)
Global AI Pathology Analysis System revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI Pathology Analysis System total market by Type, CAGR, 2021-2032, (USD Million)
Global AI Pathology Analysis System total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI Pathology Analysis System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Visiopharm, PathAI, Aiforia, Indica Labs, aetherAI, Proscia, Mindpeak, Techcyte, Qritive, Deepathology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI Pathology Analysis System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI Pathology Analysis System Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global AI Pathology Analysis System Market, Segmentation by Type:
On-premises
Cloud-based
Global AI Pathology Analysis System Market, Segmentation by Technical Architecture:
Single-Task Dedicated Model
Multi-Task General Model
Multimodal Fusion Model
Global AI Pathology Analysis System Market, Segmentation by Clinical Application Functions:
Assisted Screening System
Quantitative Analysis System
Staging and Grading System
Prognostic Prediction System
Companion Diagnostic System
Global AI Pathology Analysis System Market, Segmentation by Application:
Hospital
Clinic
Others
Companies Profiled:
Visiopharm
PathAI
Aiforia
Indica Labs
aetherAI
Proscia
Mindpeak
Techcyte
Qritive
Deepathology
Franklin.ai
Roche Diagnostics
Flagship
Dedalus Group
Ibex Medical Analytics
Key Questions Answered
1. How big is the global AI Pathology Analysis System market?
2. What is the demand of the global AI Pathology Analysis System market?
3. What is the year over year growth of the global AI Pathology Analysis System market?
4. What is the total value of the global AI Pathology Analysis System market?
5. Who are the Major Players in the global AI Pathology Analysis System market?
6. What are the growth factors driving the market demand?
Table of Contents
122 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World AI Pathology Analysis System Companies Competitive Analysis
- 4 United States VS China VS Rest of World (by Headquarter Location)
- 5 Market Analysis by Type
- 6 Market Analysis by Technical Architecture
- 7 Market Analysis by Clinical Application Functions
- 8 Market Analysis by Application
- 9 Company Profiles
- 10 Industry Chain Analysis
- 11 Research Findings and Conclusion
- 12 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

